Comparison of baseline characteristics between participants included in this follow-up study and those who refused, were lost to follow-up, or deceased
| Follow-up | Refused/lost to follow-up/deceased | |
| Male/female, n | 203/249 | 72/72 |
| Spouse/unaffected relative/FCHL, n (%) | 113/244/95 (25/54/21) | 40/77/27 (28/53/19) |
| Age, years | 43±13 | 51±17* |
| Smoking, n (%) | 136 (30) | 42 (29) |
| BMI, kg/m² | 25.7±4.0 | 26.5±4.6* |
| Waist circumference, cm | 91.0±12.2 | 94.7±13.8* |
| Total cholesterol, mmol/L | 5.6±1.3 | 5.8±1.4 |
| HDL cholesterol, mmol/L | 1.0±0.2 | 1.0±0.3 |
| LDL cholesterol, mmol/L | 3.9±1.2 | 4.1±1.3 |
| Triglycerides, mmol/L | 1.3 (0.9–1.9) | 1.4 (1.0–2.0) |
| Apolipoprotein B, g/L | 1.1±0.3 | 1.1±0.3 |
| Lipid lowering medication, n (%) | 71 (16) | 30 (22) |
| Systolic BP, mm Hg | 132±19 | 140±25* |
| Diastolic BP, mm Hg | 84±11 | 86±13 |
| Anti-hypertensive medication, n (%) | 53 (12) | 39 (27)* |
| Glucose, mmol/L | 4.9 (4.6–5.3) | 5.1 (4.7–5.5)* |
Data are expressed as mean ± SD or as medians with IQR between parentheses.
*P<0.05, analysed with a Student’s T-test, Mann-Whitney U test, and χ2 test in case of normally distributed, non-normally distributed, and dichotomous variables, respectively.
BMI, body mass index; BP, blood pressure; FCHL, familial combined hyperlipidemia; HDL, high-density lipoprotein; LDL, low-density lipoprotein.